Differential sensitivities to lactate transport inhibitors of breast cancer cell lines

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 27-38

  Morais Santos, Filipa ^a,b   Miranda Gonçalves, Vera ^a,b   Pinheiro, Sílvia ^a,b   Vieira, André F ^c   Paredes, Joana ^c   Schmitt, Fernando C ^c,d,e,f   Baltazar, Fátima ^a,b   Pinheiro, Céline ^a,b,g  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d University of Porto   (Portugal)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g Barretos School of Health Sciences   (Brazil)

Author keywords

Breast; Carcinoma; Molecular biology

Indexed keywords

CD147 ANTIGEN; GLUCOSE; LACTIC ACID; LONIDAMINE; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; QUERCETIN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL INVASION; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EVALUATION STUDY; FEMALE; GLUCOSE INTAKE; HUMAN; HUMAN CELL; IC 50; MOLECULAR THERAPY; PROTEIN EXPRESSION; TUMOR INVASION; WOUND HEALING;

BREAST; CARCINOMA; MOLECULAR BIOLOGY;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COUMARIC ACIDS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDAZOLES; INHIBITORY CONCENTRATION 50; MONOCARBOXYLIC ACID TRANSPORTERS; QUERCETIN; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84893558970     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0132     Document Type: Article

References (47)

1. Asada K, Miyamoto K, Fukutomi T, Tsuda H, Yagi Y, Wakazono K, Oishi S, Fukui H, Sugimura T & Ushijima T 2003 Reduced expression of GNA11 and silencing of MCT1 in human breast cancers. Oncology 64 380-388. (doi:10.1159/000070297)
2. Belt JA, Thomas JA, Buchsbaum RN & Racker E 1979 Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids. Biochemistry 18 3506-3511. (doi:10.1021/bi00583a011)
3. Ben-Horin H, Tassini M, Vivi A, Navon G & Kaplan O 1995 Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Cancer Research 55 2814-2821.
4. Ben-Yoseph O, Lyons JC, Song CW & Ross BD 1998 Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. Journal of Neuro-Oncology 36 149-157. (doi:10.1023/A:1005819604858)
5. Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, Cox JE, Cardon CM, Van Vranken JG, Dephoure N et al. 2012 A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337 96-100. (doi:10.1126/science.1218099)
6. Colen CB, Seraji-Bozorgzad N, Marples B, Galloway MP, Sloan AE & Mathupala SP 2006 Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery 591313-1323. (doi:10.1227/01.NEU.0000249218.65332.BF)
7. Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, Monterey MD, Galloway MP, Sloan AE & Mathupala SP 2011 Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia 13 620-632. (doi:10.1593/neo.11134)
8. Deuticke B 1982 Monocarboxylate transport in erythrocytes. Journal of Membrane Biology 70 89-103. (doi:10.1007/BF01870219)
9. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM & Wahl ML 2006 The HC-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Molecular Pharmacology 70 2108-2115. (doi:10.1124/mol.106.026245)
10. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S et al. 2007 Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109 3812-3819. (doi:10.1182/blood-2006-07-035972)
11. Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A & De Martino C 1981 Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. Journal of the National Cancer Institute 66 497-499. (doi:10.1093/jnci/66.3.497)
12. Gallagher SM, Castorino JJ, Wang D & Philp NJ 2007 Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Research 67 4182-4189. (doi:10.1158/0008-5472.CAN-06-3184)
13. Granado-Serrano AB, Martin MA, Bravo L, Goya L & Ramos S 2006 Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). Journal of Nutrition 136 2715-2721.
14. Halestrap AP 2012 The monocarboxylate transporter family - structure and functional characterization. IUBMB Life 64 1-9. (doi:10.1002/iub.573)
15. Halestrap AP & Denton RM 1974 Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by α-cyano-4-hydroxycinnamate. Biochemical Journal 138 313-316.
16. Halestrap AP & Meredith D 2004 The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflügers Archiv: European Journal of Physiology 447 619-628. (doi:10.1007/s00424-003-1067-2)
17. Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B, Kunji ER & Martinou JC 2012 Identification and functional expression of the mitochondrial pyruvate carrier. Science 337 93-96. (doi:10.1126/science.1218530)
18. Hussien R & Brooks GA 2011 Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiological Genomics 43 255-264. (doi:10.1152/physiolgenomics.00177. 2010)
19. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. Journal of Nuclear Medicine 50 1820-1827. (doi:10.2967/jnumed. 108.054098)
20. Jones NP & Schulze A 2012 Targeting cancer metabolism - aiming at a tumour's sweet-spot. Drug Discovery Today 17 232-241. (doi:10.1016/j.drudis. 2011.12.017)
21. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN & Halestrap AP 2000 CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO Journal 19 3896-3904. (doi:10.1093/emboj/19.15.3896)
22. Kopito RR 1990 Molecular biology of the anion exchanger gene family. International Review of Cytology 123 177-199. (doi:10.1016/S0074-7696(08)60674- 9)
23. Koukourakis MI, Giatromanolaki A, Harris AL & Sivridis E 2006 Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumorassociated stroma. Cancer Research 66 632-637. (doi:10.1158/0008-5472.CAN-05-3260)
24. Koukourakis MI, Giatromanolaki A, Bougioukas G & Sivridis E 2007 Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biology & Therapy 6 1476-1479. (doi:10.4161/cbt.6.9.4635)
25. Mathupala SP, Parajuli P & Sloan AE 2004 Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55 1410-1419. (doi:10.1227/01.NEU.0000143034.2913.59)
26. Mathupala SP, Colen CB, Parajuli P & Sloan AE 2007 Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis. Journal of Bioenergetics and Biomembranes 39 73-77. (doi:10.1007/s10863-006-9062-x)
27. Matos I, Dufloth R, Alvarenga M, Zeferino LC & Schmitt F 2005 p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Archiv 447 688-694. (doi:10.1007/s00428-005-0010-7)
28. Miranda-Goncalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I et al. 2013 Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology 15 172-188. (doi:10.1093/neuonc/nos298)
29. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F et al. 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 515-527. (doi:10.1016/j.ccr.2006.10.008)
30. de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C et al. 2012 Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). Journal of Bioenergetics and Biomembranes 44 171-178. (doi:10.1007/s10863-012- 9408-5)
31. Paredes J, Lopes N, Milanezi F & Schmitt FC 2007 P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Archiv 450 73-80. (doi:10.1007/s00428-006-0334-y)
32. Pinheiro C, Longatto-Filho A, Ferreira L, Pereira SM, Etlinger D, Moreira MA, Jube LF, Queiroz GS, Schmitt F & Baltazar F 2008a Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. International Journal of Gynecological Pathology 27 568-574. (doi:10.1097/PGP.0b013e31817b5b40)
33. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F & Baltazar F 2008b Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Archiv 452 139-146. (doi:10.1007/s00428-007-0558-5)
34. Pinheiro C, Longatto-Filho A, Simoes K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F & Baltazar F 2009 The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. European Journal of Cancer 45 2418-2424. (doi:10.1016/j.ejca.2009.06.018)
35. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F & Baltazar F 2010 Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56 860-867. (doi:10.1111/j.1365- 2559.2010.03560.x)
36. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F & Baltazar F 2011 GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histology and Histopathology 26 1279-1286.
37. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC & Baltazar F 2012 Role of monocarboxylate transporters in human cancers: state of the art. Journal of Bioenergetics and Biomembranes 44 127-139. (doi:10.1007/s10863-012-9428-1)
38. Pouyssegur J, Dayan F & Mazure NM 2006 Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 437-443. (doi:10.1038/nature04871)
39. Rofstad EK, Mathiesen B, Kindem K & Galappathi K 2006 Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Research 66 6699-6707. (doi:10.1158/0008-5472.CAN-06- 0983)
40. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF et al. 2008 Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. Journal of Clinical Investigation 118 3930-3942. (doi:10.1172/JCI36843)
41. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98 10869-10874. (doi:10.1073/pnas.191367098)
42. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 100 8418-8423. (doi:10.1073/pnas.0932692100)
43. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL & Liu ET 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study. PNAS 100 10393-10398. (doi:10.1073/pnas.1732912100)
44. Stern R, Shuster S, Neudecker BA & Formby B 2002 Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Experimental Cell Research 276 24-31. (doi:10.1006/excr.2002.5508)
45. Walenta S, Schroeder T & Mueller-Klieser W 2002 Metabolic mapping with bioluminescence: basic and clinical relevance. Biomolecular Engineering 18 249-262. (doi:10.1016/S1389-0344(01)00107-1)
46. Wang Q & Morris ME 2007 Flavonoids modulate monocarboxylate transporter-1-mediated transport of g-hydroxybutyrate in vitro and in vivo. Drug Metabolism and Disposition 35 201-208. (doi:10.1124/dmd.106.012369)
47. Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, Wei YH & Chung JG 2006 Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metabolism and Disposition 34 296-304. (doi:10.1124/dmd.105.005280)